GlassScriptPhysician profile
Apurva Sharma
NPI 1053868646
$12,622.72
in general payments reported to CMS, 2019-2025
21 companies · $2,723 in 2025
The $2,723 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $165 · 2021: $639 · 2022: $856 · 2023: $1,538 · 2024: $6,702 · 2025: $2,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,126 · Food and Beverage: $3,530 · Travel and Lodging: $2,938 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,126.44 |
| Food and Beverage | $3,530.41 |
| Travel and Lodging | $2,937.56 |
| Education | $368.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,565.54 | 2024-2025 | Cardiomems, Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $3,400.96 | 2022-2024 | Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $1,861.35 | 2020-2025 | Idc, Avvigo Guidance System, General - Vascular Access |
| Abiomed | $1,089.37 | 2024-2025 | Impella |
| Astellas Pharma US INC | $579.94 | 2020-2023 | |
| Shockwave Medical, INC | $522.14 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $486.66 | 2025 | Igt Devices Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.24 | 2020-2025 | Lifevest |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| Nuwellis, INC. | $118.61 | 2023 | Aquadex Smartflow Console |
| Janssen Pharmaceuticals, INC | $111.17 | 2021-2023 | Xarelto |
| Cordis US Corp. | $85.77 | 2022 | |
| Amgen INC. | $70.01 | 2024 | Repatha |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $45.29 | 2024 | Verquvo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $42.44 | 2021 | |
| Chiesi USA, INC. | $39.46 | 2020-2023 | Kengreal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.18 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $25.98 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $16.74 | 2020 | |
| Bridgebio Pharma, INC. | $16.20 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apurva Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.